• News
  • SAN DIEGO
  • Health

OncoSec Medical promotes new CFO

Veronica Vallejo. Photo courtesy of OncoSec Medical

San Diego-based OncoSec Medical Inc. (OTC: ONCS) has promoted company Vice President and Controller Veronica Vallejo to CFO.

Vallejo has more than 15 years of public accounting experience and has worked for nearly a decade in a senior management position.

Vallejo holds a bachelor's degree in business administration with an emphasis in accounting from San Diego State University. She is a certified public accountant and a member of the American Institute of Certified Public Accountants.

“Veronica has been an integral part of our team since the inception of OncoSec, and this promotion is well-deserved,” said Punit Dhillon, president and CEO. “Her strategic insights and strong financial acumen will be valuable to the future success and growth of the company.”

OncoSec Medical is a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumor cancers.

RELATED ARTICLES:

OncoSec Medical announces $7.2M public offering

OncoSec Medical gets key patent from China

Tri-City names new VP of IT

User Response
0 UserComments

OncoSec Medical Inc.

Company Website

4690 Executive Dr. Ste., 250
San Diego, CA 92121

Company Trade Data

Stock Symbol Close
Change
Chg %Chg
Volume
52-Week
High Low
ONCS
4.31
  0.25  
+ 6.16%
128,643,000
13.19
3.37

OncoSec Medical Inc. Executive(s):

Punit Dhillon

  • Chief Executive Officer, President

Veronica Vallejo

  • Chief Financial Officer